CN Stock MarketDetailed Quotes

Allgens Medical Technology (688613)

Watchlist
  • 20.60
  • +0.85+4.30%
Market Closed Apr 30 15:00 CST
2.82BMarket Cap198.08P/E (TTM)

Allgens Medical Technology (688613) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
14.65%48.68M
8.59%223.74M
5.22%156.06M
-0.20%100.04M
-10.35%42.46M
-9.03%206.03M
-19.22%148.31M
-15.05%100.24M
-0.94%47.36M
-7.68%226.48M
Operating revenue
14.65%48.68M
8.59%223.74M
5.22%156.06M
-0.20%100.04M
-10.35%42.46M
-9.03%206.03M
-19.22%148.31M
-15.05%100.24M
-0.94%47.36M
-7.68%226.48M
Total operating cost
8.71%50.71M
3.56%233.16M
4.28%162.01M
4.97%107.51M
1.76%46.64M
6.98%225.15M
8.71%155.37M
13.03%102.41M
39.96%45.84M
25.91%210.45M
Operating cost
13.96%19.01M
17.65%70.12M
28.13%48.54M
58.21%36.9M
79.51%16.68M
51.90%59.6M
22.31%37.88M
12.43%23.32M
2.29%9.29M
-3.78%39.24M
Operating tax surcharges
-4.20%1.07M
48.22%5.3M
45.37%3.79M
40.22%2.59M
29.32%1.11M
-5.64%3.57M
1.20%2.61M
-2.87%1.84M
387.89%859.95K
42.77%3.79M
Operating expense
-0.39%8.65M
16.13%55.74M
27.99%37.65M
12.83%22.7M
-8.36%8.69M
27.35%48M
8.34%29.41M
7.01%20.12M
-7.30%9.48M
20.55%37.69M
Administration expense
-12.36%12.63M
-19.71%60.7M
-30.36%43.06M
-31.52%28.66M
-20.72%14.41M
-10.38%75.6M
14.84%61.83M
27.32%41.85M
109.06%18.17M
118.05%84.35M
Financial expense
-43.19%346.07K
628.32%2.05M
307.03%1.52M
164.20%932.78K
27.71%609.14K
-232.02%-388.22K
63.48%-734.61K
-4.11%-1.45M
133.83%476.95K
96.84%-116.93K
-Interest expense (Financial expense)
----
-19.38%2.38M
-19.55%1.75M
-18.80%1.18M
----
-5.83%2.95M
38.52%2.17M
29.83%1.46M
----
67.72%3.13M
-Interest Income (Financial expense)
----
89.81%-356.5K
90.60%-293.86K
91.18%-272.09K
----
-7.16%-3.5M
-10.32%-3.13M
-22.10%-3.08M
----
41.62%-3.27M
Research and development
74.92%9M
1.24%39.25M
12.67%27.45M
-5.99%15.73M
-31.88%5.15M
-14.80%38.77M
-19.83%24.37M
-5.42%16.73M
26.37%7.55M
-20.81%45.5M
Credit Impairment Loss
----
147.21%4.36M
279.29%3.76M
278.53%3.76M
--475.49
-551.77%-9.23M
-258.78%-2.1M
-260.29%-2.11M
----
-164.21%-1.42M
Asset Impairment Loss
----
-180.42%-161.87K
----
----
----
--201.28K
----
----
----
----
Other net revenue
Fair value change income
-13.31%3.11M
105.56%13.05M
287.98%9.87M
-14.83%6.91M
-14.52%3.59M
-57.94%6.35M
-79.76%2.54M
-0.98%8.11M
4.50%4.2M
48.10%15.1M
Invest income
----
-98.93%124.27K
-99.71%39.77K
-96.15%15.86K
--9K
296.37%11.56M
7,189.29%13.61M
--411.54K
----
9,649.24%2.92M
Asset deal income
-144.08%-88.68K
-27.10%464.68K
-76.07%154.09K
-77.18%170.57K
5,532.86%201.19K
208.24%637.45K
--643.91K
--747.53K
---3.7K
-81.52%-588.94K
Other revenue
-25.97%139.83K
59.79%3.58M
871.94%2.85M
633.31%2.12M
119.97%188.88K
-86.80%2.24M
-80.01%293.57K
-75.22%289.63K
-27.95%85.87K
92.70%16.96M
Adjusted Items effecting operating profit
----
----
----
----
--0.01
----
----
----
----
----
Operating profit
692.36%1.14M
263.00%12M
35.08%10.72M
4.32%5.51M
-103.31%-192.41K
-115.02%-7.36M
-85.39%7.94M
-85.40%5.28M
-69.74%5.81M
-49.13%48.99M
Add:Non operating Income
----
244.65%292.34K
3,228,732.98%30.35K
3,151,624.47%29.63K
----
-56.12%84.82K
-99.99%0.94
-99.99%0.94
----
--193.31K
Less:Non operating expense
274.91%1.1K
-99.81%3.15K
-99.82%2.69K
-99.82%294.35
-99.82%294.35
1,682.44%1.66M
1,521.42%1.5M
1,547.96%164.91K
1,548.46%164.85K
-18.86%93.15K
Total profit
690.89%1.14M
237.50%12.29M
67.02%10.75M
8.26%5.54M
-103.41%-192.71K
-118.20%-8.94M
-88.14%6.43M
-85.86%5.12M
-70.60%5.65M
-48.97%49.09M
Less:Income tax cost
--620.09K
-66.05%2.79M
-97.92%150.79K
-99.21%1.37K
----
311.85%8.2M
197.94%7.24M
-92.91%172.32K
-89.46%256.29K
-186.01%-3.87M
Add:Adjusted items effecting net profit
--0.01
----
----
----
----
----
----
----
----
----
Net profit
369.11%518.61K
155.44%9.5M
1,407.31%10.6M
12.00%5.54M
-103.58%-192.71K
-132.36%-17.14M
-101.56%-810.5K
-85.35%4.94M
-67.87%5.39M
-42.24%52.97M
Net profit from continuing operation
369.11%518.61K
155.44%9.5M
1,407.31%10.6M
12.00%5.54M
-103.58%-192.71K
-132.36%-17.14M
-101.56%-810.5K
-85.35%4.94M
-67.87%5.39M
-42.24%52.97M
Less:Minority Profit
27.70%-892.37K
3.13%-4.34M
41.31%-3.34M
43.00%-2.44M
20.31%-1.23M
-253.80%-4.48M
-158.23%-5.7M
-156.04%-4.28M
11.07%-1.55M
64.03%-1.27M
Net profit of parent company owners
35.47%1.41M
209.30%13.84M
185.19%13.94M
-13.52%7.98M
-84.99%1.04M
-123.35%-12.66M
-90.95%4.89M
-73.96%9.22M
-62.52%6.94M
-43.04%54.23M
Earning per share
Basic earning per share
0.00%0.01
211.11%0.1
150.00%0.1
-14.29%0.06
-80.00%0.01
-121.95%-0.09
-90.24%0.04
-74.07%0.07
-64.29%0.05
-42.25%0.41
Diluted earning per share
0.00%0.01
211.11%0.1
150.00%0.1
-14.29%0.06
-80.00%0.01
-121.95%-0.09
-90.24%0.04
-74.07%0.07
-64.29%0.05
-42.25%0.41
Other composite income
-238.74%-389.69K
251.42%444.84K
2,965.58%770.23K
27,722.02%1.05M
280.87K
-28.67%-293.78K
25.13K
-3.81K
23.21%-228.31K
Other composite income of parent company owners
-238.74%-389.69K
251.42%444.84K
2,965.58%770.23K
27,722.02%1.05M
--280.87K
-28.67%-293.78K
--25.13K
---3.81K
----
23.21%-228.31K
Total composite income
46.23%128.92K
157.06%9.95M
1,547.21%11.37M
33.42%6.59M
-98.36%88.16K
-133.06%-17.43M
-101.52%-785.37K
-85.36%4.94M
-67.87%5.39M
-42.30%52.74M
Total composite income of parent company owners
-22.77%1.02M
210.25%14.28M
199.40%14.71M
-2.05%9.03M
-80.94%1.32M
-123.99%-12.96M
-90.90%4.91M
-73.97%9.22M
-62.52%6.94M
-43.11%54M
Total composite income of minority owners
27.70%-892.37K
3.13%-4.34M
41.31%-3.34M
43.00%-2.44M
20.31%-1.23M
-253.80%-4.48M
-158.23%-5.7M
-156.04%-4.28M
11.07%-1.55M
64.03%-1.27M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
--
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 14.65%48.68M8.59%223.74M5.22%156.06M-0.20%100.04M-10.35%42.46M-9.03%206.03M-19.22%148.31M-15.05%100.24M-0.94%47.36M-7.68%226.48M
Operating revenue 14.65%48.68M8.59%223.74M5.22%156.06M-0.20%100.04M-10.35%42.46M-9.03%206.03M-19.22%148.31M-15.05%100.24M-0.94%47.36M-7.68%226.48M
Total operating cost 8.71%50.71M3.56%233.16M4.28%162.01M4.97%107.51M1.76%46.64M6.98%225.15M8.71%155.37M13.03%102.41M39.96%45.84M25.91%210.45M
Operating cost 13.96%19.01M17.65%70.12M28.13%48.54M58.21%36.9M79.51%16.68M51.90%59.6M22.31%37.88M12.43%23.32M2.29%9.29M-3.78%39.24M
Operating tax surcharges -4.20%1.07M48.22%5.3M45.37%3.79M40.22%2.59M29.32%1.11M-5.64%3.57M1.20%2.61M-2.87%1.84M387.89%859.95K42.77%3.79M
Operating expense -0.39%8.65M16.13%55.74M27.99%37.65M12.83%22.7M-8.36%8.69M27.35%48M8.34%29.41M7.01%20.12M-7.30%9.48M20.55%37.69M
Administration expense -12.36%12.63M-19.71%60.7M-30.36%43.06M-31.52%28.66M-20.72%14.41M-10.38%75.6M14.84%61.83M27.32%41.85M109.06%18.17M118.05%84.35M
Financial expense -43.19%346.07K628.32%2.05M307.03%1.52M164.20%932.78K27.71%609.14K-232.02%-388.22K63.48%-734.61K-4.11%-1.45M133.83%476.95K96.84%-116.93K
-Interest expense (Financial expense) -----19.38%2.38M-19.55%1.75M-18.80%1.18M-----5.83%2.95M38.52%2.17M29.83%1.46M----67.72%3.13M
-Interest Income (Financial expense) ----89.81%-356.5K90.60%-293.86K91.18%-272.09K-----7.16%-3.5M-10.32%-3.13M-22.10%-3.08M----41.62%-3.27M
Research and development 74.92%9M1.24%39.25M12.67%27.45M-5.99%15.73M-31.88%5.15M-14.80%38.77M-19.83%24.37M-5.42%16.73M26.37%7.55M-20.81%45.5M
Credit Impairment Loss ----147.21%4.36M279.29%3.76M278.53%3.76M--475.49-551.77%-9.23M-258.78%-2.1M-260.29%-2.11M-----164.21%-1.42M
Asset Impairment Loss -----180.42%-161.87K--------------201.28K----------------
Other net revenue
Fair value change income -13.31%3.11M105.56%13.05M287.98%9.87M-14.83%6.91M-14.52%3.59M-57.94%6.35M-79.76%2.54M-0.98%8.11M4.50%4.2M48.10%15.1M
Invest income -----98.93%124.27K-99.71%39.77K-96.15%15.86K--9K296.37%11.56M7,189.29%13.61M--411.54K----9,649.24%2.92M
Asset deal income -144.08%-88.68K-27.10%464.68K-76.07%154.09K-77.18%170.57K5,532.86%201.19K208.24%637.45K--643.91K--747.53K---3.7K-81.52%-588.94K
Other revenue -25.97%139.83K59.79%3.58M871.94%2.85M633.31%2.12M119.97%188.88K-86.80%2.24M-80.01%293.57K-75.22%289.63K-27.95%85.87K92.70%16.96M
Adjusted Items effecting operating profit ------------------0.01--------------------
Operating profit 692.36%1.14M263.00%12M35.08%10.72M4.32%5.51M-103.31%-192.41K-115.02%-7.36M-85.39%7.94M-85.40%5.28M-69.74%5.81M-49.13%48.99M
Add:Non operating Income ----244.65%292.34K3,228,732.98%30.35K3,151,624.47%29.63K-----56.12%84.82K-99.99%0.94-99.99%0.94------193.31K
Less:Non operating expense 274.91%1.1K-99.81%3.15K-99.82%2.69K-99.82%294.35-99.82%294.351,682.44%1.66M1,521.42%1.5M1,547.96%164.91K1,548.46%164.85K-18.86%93.15K
Total profit 690.89%1.14M237.50%12.29M67.02%10.75M8.26%5.54M-103.41%-192.71K-118.20%-8.94M-88.14%6.43M-85.86%5.12M-70.60%5.65M-48.97%49.09M
Less:Income tax cost --620.09K-66.05%2.79M-97.92%150.79K-99.21%1.37K----311.85%8.2M197.94%7.24M-92.91%172.32K-89.46%256.29K-186.01%-3.87M
Add:Adjusted items effecting net profit --0.01------------------------------------
Net profit 369.11%518.61K155.44%9.5M1,407.31%10.6M12.00%5.54M-103.58%-192.71K-132.36%-17.14M-101.56%-810.5K-85.35%4.94M-67.87%5.39M-42.24%52.97M
Net profit from continuing operation 369.11%518.61K155.44%9.5M1,407.31%10.6M12.00%5.54M-103.58%-192.71K-132.36%-17.14M-101.56%-810.5K-85.35%4.94M-67.87%5.39M-42.24%52.97M
Less:Minority Profit 27.70%-892.37K3.13%-4.34M41.31%-3.34M43.00%-2.44M20.31%-1.23M-253.80%-4.48M-158.23%-5.7M-156.04%-4.28M11.07%-1.55M64.03%-1.27M
Net profit of parent company owners 35.47%1.41M209.30%13.84M185.19%13.94M-13.52%7.98M-84.99%1.04M-123.35%-12.66M-90.95%4.89M-73.96%9.22M-62.52%6.94M-43.04%54.23M
Earning per share
Basic earning per share 0.00%0.01211.11%0.1150.00%0.1-14.29%0.06-80.00%0.01-121.95%-0.09-90.24%0.04-74.07%0.07-64.29%0.05-42.25%0.41
Diluted earning per share 0.00%0.01211.11%0.1150.00%0.1-14.29%0.06-80.00%0.01-121.95%-0.09-90.24%0.04-74.07%0.07-64.29%0.05-42.25%0.41
Other composite income -238.74%-389.69K251.42%444.84K2,965.58%770.23K27,722.02%1.05M280.87K-28.67%-293.78K25.13K-3.81K23.21%-228.31K
Other composite income of parent company owners -238.74%-389.69K251.42%444.84K2,965.58%770.23K27,722.02%1.05M--280.87K-28.67%-293.78K--25.13K---3.81K----23.21%-228.31K
Total composite income 46.23%128.92K157.06%9.95M1,547.21%11.37M33.42%6.59M-98.36%88.16K-133.06%-17.43M-101.52%-785.37K-85.36%4.94M-67.87%5.39M-42.30%52.74M
Total composite income of parent company owners -22.77%1.02M210.25%14.28M199.40%14.71M-2.05%9.03M-80.94%1.32M-123.99%-12.96M-90.90%4.91M-73.97%9.22M-62.52%6.94M-43.11%54M
Total composite income of minority owners 27.70%-892.37K3.13%-4.34M41.31%-3.34M43.00%-2.44M20.31%-1.23M-253.80%-4.48M-158.23%-5.7M-156.04%-4.28M11.07%-1.55M64.03%-1.27M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------------------Unqualified opinion
Auditor ------------------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Iran has announced its latest negotiation proposal: all issues should be resolved within 30 days, with the focus on 'ending the war' rather Show More